Residual host cell DNA can remain in biologic drug products after purification. Sensitive residual DNA detection methods are required to monitor and control these impurities.
Common Detection Technologies
- Quantitative PCR (qPCR)
- Digital PCR
- DNA-binding assays
PCR-based assays are widely used due to their high sensitivity and specificity.